Drugmaker Fidson plans N1bn dividend and free shares for shareholders

Fidson Healthcare is to pay shareholders more than 1 billion naira in dividends and also issue them one new share for every 10 they hold in the company, both representing the expected compensation for holders of its ordinary shares for the 2021 financial year.

The cash reward proposal provides shareholders with a dividend of 0.50 naira per share, with a qualifying date as well as issuance of certificates set for July 8, the pharmaceutical company said in a statement on Friday. note to the Nigerian Exchange Limited. .

Fidson will have distributed 208.6 million new shares when settlement of the bonus issue is complete and dusted.

Surprisingly, Fidson's share price fell 2.4% in Lagos after the news.

Fidelis A. Ayebae, Managing Director Fidson HealthcareFidelis A. Ayebae, Managing Director Fidson Healthcare < /em>

The proposed payment exceeds that of 2020 by two and marks the high point of a particularly successful year for Fidson, when after-tax profit soared 208% to 3.7 billion naira and revenue up nearly 70% to 30.9 billion naira.

In anticipation of the payment of cash and the issuance of free shares, "the register of shareholders will be closed from July 11, 2022 to July 15, 2022 inclusive", according to the document consulted by PREMIUM TIMES.

Payment is due July 29 and will be made electronically to shareholders whose names appear on the company's register of members from July 8.

They will be eligible to receive the dividend provided they complete their Electronic Dividend Warrant Form and submit it to the Registrar, Meristem Registrars and Probate Services Limited.

In a separate memo on Friday, the drugmaker announced July 28 as the date for its 23rd annual general meeting, where a review of its audited accounts for the past year will be conducted under the full gaze of shareholders and investors. public.

Support the integrity and credibility journalism of PREMIUM TIMES Good journalism costs a lot of money. Yet only good journalism can guarantee the possibility of a good society, an accountable democracy and a transparent government. For free and continued access to the best investigative journalism in the country, we ask that you consider providing modest support to this noble endeavour. By contributing to PREMIUM TIMES, you help sustain relevant journalism and keep it free and accessible to everyone.

Donate

TEXT ANNOUNCEMENT: Call Willie - +2348098788999

PT Publicity advertising campaign

Drugmaker Fidson plans N1bn dividend and free shares for shareholders

Fidson Healthcare is to pay shareholders more than 1 billion naira in dividends and also issue them one new share for every 10 they hold in the company, both representing the expected compensation for holders of its ordinary shares for the 2021 financial year.

The cash reward proposal provides shareholders with a dividend of 0.50 naira per share, with a qualifying date as well as issuance of certificates set for July 8, the pharmaceutical company said in a statement on Friday. note to the Nigerian Exchange Limited. .

Fidson will have distributed 208.6 million new shares when settlement of the bonus issue is complete and dusted.

Surprisingly, Fidson's share price fell 2.4% in Lagos after the news.

Fidelis A. Ayebae, Managing Director Fidson HealthcareFidelis A. Ayebae, Managing Director Fidson Healthcare < /em>

The proposed payment exceeds that of 2020 by two and marks the high point of a particularly successful year for Fidson, when after-tax profit soared 208% to 3.7 billion naira and revenue up nearly 70% to 30.9 billion naira.

In anticipation of the payment of cash and the issuance of free shares, "the register of shareholders will be closed from July 11, 2022 to July 15, 2022 inclusive", according to the document consulted by PREMIUM TIMES.

Payment is due July 29 and will be made electronically to shareholders whose names appear on the company's register of members from July 8.

They will be eligible to receive the dividend provided they complete their Electronic Dividend Warrant Form and submit it to the Registrar, Meristem Registrars and Probate Services Limited.

In a separate memo on Friday, the drugmaker announced July 28 as the date for its 23rd annual general meeting, where a review of its audited accounts for the past year will be conducted under the full gaze of shareholders and investors. public.

Support the integrity and credibility journalism of PREMIUM TIMES Good journalism costs a lot of money. Yet only good journalism can guarantee the possibility of a good society, an accountable democracy and a transparent government. For free and continued access to the best investigative journalism in the country, we ask that you consider providing modest support to this noble endeavour. By contributing to PREMIUM TIMES, you help sustain relevant journalism and keep it free and accessible to everyone.

Donate

TEXT ANNOUNCEMENT: Call Willie - +2348098788999

PT Publicity advertising campaign

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow